PROCEPT BioRobotics Corporation (PRCT) Financial Statements (2023 and earlier)

Company Profile

Business Address 900 ISLAND DRIVE
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments221,859304,320
Cash and cash equivalents221,859304,320
Restricted cash and investments3,815777
Receivables15,2724,464
Inventory, net of allowances, customer advances and progress billings28,54313,147
Inventory28,54313,147
Prepaid expense  2,984
Other undisclosed current assets3,137481
Total current assets:272,626326,173
Noncurrent Assets
Operating lease, right-of-use asset23,4813,279
Property, plant and equipment8,6565,045
Intangible assets, net (including goodwill), including:1,4771,750
Intangible assets, net (excluding goodwill) (1,000)(800)
Other undisclosed intangible assets, net (including goodwill)2,4772,550
Restricted cash and investments3,038777
Other noncurrent assets51 
Total noncurrent assets:36,70310,851
TOTAL ASSETS:309,329337,024
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22,8388,504
Employee-related liabilities6,475
Accounts payable9,3912,029
Accrued liabilities13,447 
Deferred revenue2,8551,025
Other liabilities7,4684,608
Other undisclosed current liabilities2,1292,105
Total current liabilities:35,29016,242
Noncurrent Liabilities
Long-term debt and lease obligation51,21351,995
Long-term debt, excluding current maturities51,21350,004
Liabilities, other than long-term debt25,7541,696
Deferred revenue  
Other liabilities  200
Operating lease, liability23,9751,991
Derivative instruments and hedges, liabilities1,7791,496
Total noncurrent liabilities:76,96753,691
Total liabilities:112,25769,933
Equity
Equity, attributable to parent197,072267,091
Additional paid in capital545,753528,666
Accumulated other comprehensive loss(6)(54)
Accumulated deficit(348,675)(261,521)
Total equity:197,072267,091
TOTAL LIABILITIES AND EQUITY:309,329337,024

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
Revenues75,01434,473
Cost of revenue(37,929)(18,608)
Gross profit:37,08515,865
Operating expenses(117,809)(70,029)
Operating loss:(80,724)(54,164)
Nonoperating income 2,01157
Investment income, nonoperating 2,214211
Other nonoperating expense (203)(154)
Interest and debt expense(8,441)(5,810)
Other undisclosed income from continuing operations before equity method investments, income taxes  
Loss from continuing operations:(87,154)(59,917)
Loss before gain (loss) on sale of properties:(59,917)
Net loss:(87,154)(59,917)
Other undisclosed net income attributable to parent 64
Net loss available to common stockholders, diluted:(87,154)(59,853)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
Net loss:(87,154)(59,917)
Comprehensive loss:(87,154)(59,917)
Other undisclosed comprehensive income, net of tax, attributable to parent4824
Comprehensive loss, net of tax, attributable to parent:(87,106)(59,893)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: